Evidence map›Paper›PMID 42338048›Full record

SynthesisVeterinary medicine and science2026

Systematic Review of Intravenous Ceftriaxone Administration in Animals.

Paula Maria Fernandes de Vasconcelos, Gabriel de Brito Rodrigues, Michel Leandro de Campos

Abstract readSystematic Review
In one paragraph

Synthesis in Veterinary medicine and science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Paula Maria Fernandes de VasconcelosInstituto de Ciências da Saúde, Universidade Federal de Mato Grosso, Sinop, Mato Grosso, Brazil.
Gabriel de Brito RodriguesInstituto de Ciências da Saúde, Universidade Federal de Mato Grosso, Sinop, Mato Grosso, Brazil.
Michel Leandro de CamposInstituto de Ciências da Saúde, Universidade Federal de Mato Grosso, Sinop, Mato Grosso, Brazil.

Funding

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) under the Social Demand Program 88887.14400/2025-00Fundação de Amparo À Pesquisa do Estado de Mato Grosso FAPEMAT-PRO.000513/2023Universidade Federal de Mato Grosso (UFMT)
6 · The paper itself

Abstract

backgroundCeftriaxone is an antibiotic frequently prescribed in veterinary medical practice due to its effectiveness against several pathogenic microorganisms responsible for diseases in different animal species.

objectiveTo select scientific articles from the academic databases PubMed and Web of Science that analysed the pharmacokinetic aspects of intravenously administered ceftriaxone in animals.

methodsIn accordance with the principles of scientific transparency, the systematic review protocol and all research stages were previously registered on the Open Science Framework (OSF) platform. The scientific articles that met the inclusion criteria were subjected to a checklist comprising 24 minimum assessment items designed for reporting pharmacokinetic studies.

resultsA total of 52 pharmacokinetic profiles were identified from the 29 selected scientific articles, including records involving 13 different animal species used in ceftriaxone experimental studies.

conclusionThe limitations and inconsistencies identified in this review highlight the importance of detailed reporting of pharmacokinetic data derived from experimental trials in animals.

Indexed as

Anti-Bacterial AgentsCeftriaxoneAdministration, IntravenousAnimalsSecond Generation CephalosporinsAnti-Bacterial AgentsCeftriaxoneSecond Generation Cephalosporinsanimalantibioticceftriaxonepharmacokineticspharmacology

Identifiers

PMID42338048
PMCPMC13291184

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.